AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Maindrault-Goebel, F de Gramont, A Louvet, C Andre, T Carola, E Mabro, M Artru, P Gilles, V Lotz, JP Izrael, V Krulik, M
Citation: F. Maindrault-goebel et al., High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7), EUR J CANC, 37(8), 2001, pp. 1000-1005

Authors: Artru, P Tournigand, C Mabro, M Lucchi, E Louvet, C De Gramont, A Krulik, M
Citation: P. Artru et al., Primary hyperparathyroidism associated with colon cancer, GASTRO CL B, 25(2), 2001, pp. 208-209

Authors: Maindrault-Goebel, F de Gramont, A Louvet, C Andre, T Carola, E Gilles, V Lotz, JP Tournigand, C Mabro, M Molitor, JL Artru, P Izrael, V Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483

Authors: Mabro, M Blanc, AS Briant, M Tiev, KP Bletry, O Cabane, J
Citation: M. Mabro et al., Paraneoplastic cough in three patients with renal cell carcinoma, PRESSE MED, 29(16), 2000, pp. 891-893

Authors: Mabro, M de Gramont, A
Citation: M. Mabro et A. De Gramont, Aspirin against cancer., REV MED IN, 21, 2000, pp. 60S-67S

Authors: Sharshar, T Auriant, I Dorandeu, A Saghatchian, M Belec, L Benyahia, B Mabro, M Raphael, JC Gajdos, P Delattre, JY Gray, F
Citation: T. Sharshar et al., Association of herpes simplex virus encephalitis and paraneoplastic encephalitis - A clinico-pathological study, ANN PATHOL, 20(3), 2000, pp. 249-252

Authors: Mabro, M Cohn, R Zanesco, L Madon, E Hahlen, K Marguerite, G Breatnach, F Gentet, JC Plouvier, E
Citation: M. Mabro et al., Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of two doses, B CANCER, 87(3), 2000, pp. 259-264

Authors: Andre, T Louvet, C Maindrault-Goebel, F Couteau, C Mabro, M Lotz, JP Gilles-Amar, V Krulik, M Carola, E Izrael, V de Gramont, A
Citation: T. Andre et al., CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer, EUR J CANC, 35(9), 1999, pp. 1343-1347

Authors: Mabro, M
Citation: M. Mabro, Progress in anticancer treatments, PRESSE MED, 28(14), 1999, pp. 745-746

Authors: Mabro, M Gilles-Amar, V Louvet, C Carola, E Maindrault-Goebel, F de Gramont, A Krulik, M
Citation: M. Mabro et al., Bimonthly fluorouracil in elderly patients with metastatic colorectal cancer: a report of 50 patients., REV MED IN, 20(10), 1999, pp. 863-868

Authors: Mabro, M Faivre, S Raymond, E
Citation: M. Mabro et al., A risk-benefit assessment of amifostine in cytoprotection, DRUG SAFETY, 21(5), 1999, pp. 367-387

Authors: Mabro, M Kerbrat, P
Citation: M. Mabro et P. Kerbrat, Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer, B CANCER, 86(3), 1999, pp. 295-301
Risultati: 1-12 |